myriad genetics glp-1 receptor agonist weight management diabetes treatments Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Frontiers | GLP−1 receptor agonists

Understanding potential drug interactions, contraindications, and individual health factors helps ensure safe, effective treatment and prevents adverse events

The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

Discover Ozempic alternatives for type 2 diabetes and weight loss, including GLP-1s and oral medications

Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials